Annual Short Term Debt
$413.70 M
-$543.60 M-56.78%
31 December 2023
Summary:
Emergent BioSolutions annual short term debt is currently $413.70 million, with the most recent change of -$543.60 million (-56.78%) on 31 December 2023. During the last 3 years, it has risen by +$379.90 million (+1123.96%). EBS annual short term debt is now -56.78% below its all-time high of $957.30 million, reached on 31 December 2022.EBS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$800.00 K
-$414.40 M-99.81%
30 September 2024
Summary:
Emergent BioSolutions quarterly short term debt is currently $800.00 thousand, with the most recent change of -$414.40 million (-99.81%) on 30 September 2024. Over the past year, it has dropped by -$412.80 million (-99.81%). EBS quarterly short term debt is now -99.92% below its all-time high of $957.30 million, reached on 31 December 2022.EBS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.8% | -99.8% |
| 3 y3 years | +1124.0% | -97.5% |
| 5 y5 years | +3996.0% | -92.1% |
EBS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.8% | +1209.2% | -99.9% | at low |
| 5 y | 5 years | -56.8% | +3996.0% | -99.9% | at low |
| alltime | all time | -56.8% | -99.9% |
Emergent BioSolutions Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $800.00 K(-99.8%) |
| June 2024 | - | $415.20 M(-9.6%) |
| Mar 2024 | - | $459.20 M(+11.0%) |
| Dec 2023 | $413.70 M(-56.8%) | $413.70 M(+0.0%) |
| Sept 2023 | - | $413.60 M(-9.1%) |
| June 2023 | - | $455.20 M(-52.1%) |
| Mar 2023 | - | $950.70 M(-0.7%) |
| Dec 2022 | $957.30 M(+2929.4%) | $957.30 M(+4415.6%) |
| Sept 2022 | - | $21.20 M(-32.9%) |
| June 2022 | - | $31.60 M(0.0%) |
| Mar 2022 | - | $31.60 M(0.0%) |
| Dec 2021 | $31.60 M(-6.5%) | $31.60 M(0.0%) |
| Sept 2021 | - | $31.60 M(+9.7%) |
| June 2021 | - | $28.80 M(+10.8%) |
| Mar 2021 | - | $26.00 M(-23.1%) |
| Dec 2020 | $33.80 M(+162.0%) | $33.80 M(+9.4%) |
| Sept 2020 | - | $30.90 M(+6.2%) |
| June 2020 | - | $29.10 M(+10.6%) |
| Mar 2020 | - | $26.30 M(+103.9%) |
| Dec 2019 | $12.90 M(+27.7%) | $12.90 M(+27.7%) |
| Sept 2019 | - | $10.10 M(0.0%) |
| June 2019 | - | $10.10 M(0.0%) |
| Mar 2019 | - | $10.10 M(0.0%) |
| Dec 2018 | $10.10 M(-49.5%) | $10.10 M(>+9900.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $20.00 M(>+9900.0%) | $20.00 M(0.0%) |
| Sept 2016 | - | $20.00 M(>+9900.0%) |
| Dec 2015 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | - | $4.47 M(0.0%) |
| June 2013 | - | $4.47 M(0.0%) |
| Mar 2013 | - | $4.47 M(0.0%) |
| Dec 2012 | $4.47 M(-16.6%) | $4.47 M(+7.8%) |
| Sept 2012 | - | $4.15 M(+2.2%) |
| June 2012 | - | $4.06 M(+23.7%) |
| Mar 2012 | - | $3.28 M(-38.8%) |
| Dec 2011 | $5.36 M(-68.8%) | $5.36 M(+8.9%) |
| Sept 2011 | - | $4.92 M(-51.9%) |
| June 2011 | - | $10.23 M(-39.6%) |
| Mar 2011 | - | $16.93 M(-1.5%) |
| Dec 2010 | $17.19 M(-17.3%) | $17.19 M(+42.8%) |
| Sept 2010 | - | $12.04 M(-1.2%) |
| June 2010 | - | $12.19 M(-41.4%) |
| Mar 2010 | - | $20.80 M(+0.0%) |
| Dec 2009 | $20.79 M(-2.2%) | $20.79 M(+8.9%) |
| Sept 2009 | - | $19.09 M(-44.4%) |
| June 2009 | - | $34.31 M(+60.9%) |
| Mar 2009 | - | $21.32 M(+0.3%) |
| Dec 2008 | $21.25 M(+38.5%) | $21.25 M(+13.4%) |
| Sept 2008 | - | $18.74 M(+0.2%) |
| June 2008 | - | $18.71 M(+1.0%) |
| Mar 2008 | - | $18.52 M(+20.7%) |
| Dec 2007 | $15.35 M(+34.6%) | $15.35 M(+340.3%) |
| Sept 2007 | - | $3.48 M(+34.2%) |
| June 2007 | - | $2.60 M(-1.6%) |
| Mar 2007 | - | $2.64 M(-76.9%) |
| Dec 2006 | $11.40 M(+709.9%) | $11.40 M(+191.0%) |
| Sept 2006 | - | $3.92 M(+178.3%) |
| Dec 2005 | $1.41 M(+34.6%) | $1.41 M(+34.6%) |
| Dec 2004 | $1.05 M | $1.05 M |
FAQ
- What is Emergent BioSolutions annual short term debt?
- What is the all time high annual short term debt for Emergent BioSolutions?
- What is Emergent BioSolutions annual short term debt year-on-year change?
- What is Emergent BioSolutions quarterly short term debt?
- What is the all time high quarterly short term debt for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly short term debt year-on-year change?
What is Emergent BioSolutions annual short term debt?
The current annual short term debt of EBS is $413.70 M
What is the all time high annual short term debt for Emergent BioSolutions?
Emergent BioSolutions all-time high annual short term debt is $957.30 M
What is Emergent BioSolutions annual short term debt year-on-year change?
Over the past year, EBS annual short term debt has changed by -$543.60 M (-56.78%)
What is Emergent BioSolutions quarterly short term debt?
The current quarterly short term debt of EBS is $800.00 K
What is the all time high quarterly short term debt for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly short term debt is $957.30 M
What is Emergent BioSolutions quarterly short term debt year-on-year change?
Over the past year, EBS quarterly short term debt has changed by -$412.80 M (-99.81%)